The recent and successful study of InnoStudio and CycloLab for COVID-19 drug research in space has been gaining attention and receiving positive feedback worldwide. The Roscosmos State Corporation for Space Activities found our idea and experiment valuable enough to be mentioned in its own space journal.
Read the full article (Russian) at:
Samples for COVID-19 drug research experiment by InnoStudio and CycloLab are going to be launched to the ISS within the upcoming SpX CRS-24 mission on December 21. Validation of the results of our earlier study on COVID-19 drug research in space is targeted. In case...